EXACT Sciences Corporation Stock News

With inflation under control, and economic growth still strong, there should be plenty of winning stocks between now and the end of the year. In fact, consider this.

At the end of September, Cathie Wood sat down with Morningstar to discuss the current and future state of Ark Invest, including the investment management firm's flagship fund, the ARK Innovation ETF (

There's no doubt that America is aging. The numbers do not lie.

Investors remain optimistic about Exact Sciences (EXAS) due to its strategic prioritization and positive solvency.

MADISON, Wis. , Oct. 9, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its thi

MADISON, Wis. , Oct. 9, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company will present late-break

Exact Sciences and Guardant Health have both enjoyed triple-digit revenue growth over the past five years. Exact Sciences' shares are up more than 31% so far this year, while Guardant is up a little m

Exact Sciences (EXAS) is planning several key milestones to bring six innovative cancer diagnostics from its pipeline to patients in need.

Here is how Exact Sciences (EXAS) and Anebulo Pharmaceuticals, Inc. (ANEB) have performed compared to their sector so far this year.

Cathie Wood is a thematic investor focused on disruptive new technologies. Recursion Pharmaceuticals could radically transform the drug discovery/development process.

Exact Sciences is developing a newer version of its crown jewel that could be an important addition. Its working on other products as well, some of which should hit the market within five years.

Exact Sciences (EXAS) is improving customer experience by making it simpler to order Cologuard electronically and continue re-screening of patients every three years.

Investors are optimistic about Exact Sciences (EXAS), backed by Cologuard growth and upbeat guidance.

I disagree with Cathie Wood's stock picks much if not most of the time. For example, I believe that her huge bullishness on Bitcoin ( BTC-USD ) is completely misplaced, given the clear opposition of

MADISON, Wis. , Sept. 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate